Inter Costal Catheters for Video-Assisted Thoroscopic (VATS) Lobectomy

Lung Cancer Patients Clinical Trial

Official title:

Pain Relief After VATS Lobectomy Using Interoperatively Placed Inter Costal Catheters.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01213654
• Other study ID #: VATS-IC-2010
• Status: Completed
• Phase: N/A
• First received: October 1, 2010
• Last updated: October 1, 2010
• Start date: April 2010
• Est. completion date: September 2010

Study information

• Verified date: October 2010
• Source: Rigshospitalet, Denmark
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: Danish Board of Health
• Study type: Observational

Clinical Trial Summary

A pilot study to observe satisfaction of analgesia with intercostal catheters after VATS lobectomy.

Description:

Pain and satisfaction with pain treatment is investigated in a population after VATS lobectomy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: September 2010
• Est. primary completion date: September 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Age of consent (ie age>=18) Eligible for lobectomy Able to comply Willing to register postoperatively

Exclusion Criteria:

• do not understand DAnish

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Lung Cancer Patients

Locations

Country	Name	City	State
Denmark	Rigshospitalet	Copenhagen

Sponsors (5)

Lead Sponsor	Collaborator
Rigshospitalet, Denmark	all Blegdamsvej 9, 2100-Copenhagen, Denmark, Dept. of cardio-thoracic anaesthesia, Dept. of thoracic Surgery, Dept. Surgical PAthophysiology

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	NRS (pain score 0-10))	Painscore	Until discharge (2-4 days)	No
Primary	satisfaction (Verbal ranking scale 1-4)	qualitative measurement	until discharge, 2-4 days	No
Secondary	Side effects (quantitatively, see details)	Daily presence of, Nausea Dizziness Vomiting Sedation Pruritus	until discharge, 2-4 days	Yes